Medartis Holding P/E 2024

Medartis Holding Aktienanalyse

What does Medartis Holding do?

Medartis Holding AG is a Swiss company specializing in the development and manufacturing of implants and instruments for traumatology, hand and foot surgery, and upper and lower limb reconstruction. The company was founded in 1997 by a group of doctors who decided to develop innovative products that meet the needs of patients and surgeons. The business model of Medartis is based on the sale of implants and instruments developed in close collaboration with leading surgeons. The company places particular emphasis on the use of high-quality materials and high processing quality. With this philosophy, the company has quickly gained an excellent reputation, which is also reflected in the increasing demand for its products. The company is divided into various specialized areas, each offering specialized products and solutions. One of Medartis' main areas is traumatology, which specializes in the treatment of injuries and fractures. In this area, the company offers a variety of implants and instruments tailored to the needs of surgeons and patients. Products such as plates, screws, and nails ensure that bone fractures can be stabilized and healed. Another important area of Medartis is hand surgery. Here, the company has a wide portfolio of implants and instruments tailored to the specific requirements of hand operations. One of the well-known solutions is the finger fixator, a small but very effective device used in the treatment of finger fractures. In the field of foot surgery, Medartis also offers a variety of solutions. From implants for stabilizing ankle and foot joints to instruments for correcting deformities, the company has a broad range of products. Particularly noteworthy are the implants and instruments used in the treatment of hallux valgus, commonly known as bunions. In addition to these traditional areas, Medartis also has products and solutions in its portfolio specialized in the reconstruction of the upper and lower limbs. These include implants and instruments for the treatment of spinal injuries as well as solutions for the reconstruction of knee or hip joints. Overall, in recent years, Medartis has established itself as one of the leading providers of implants and instruments in the field of traumatology, hand and foot surgery, and upper and lower limb reconstruction. With its innovative product range and high-quality standards, the company has gained an excellent reputation that will continue to drive increasing demand in the future. Medartis Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Medartis Holding's P/E Ratio

The Price to Earnings (P/E) Ratio of Medartis Holding is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Medartis Holding's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Medartis Holding is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Medartis Holding’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Medartis Holding Stock

What is the price-to-earnings ratio of Medartis Holding?

The price-earnings ratio of Medartis Holding is currently 88.6.

How has the price-earnings ratio of Medartis Holding changed compared to last year?

The price-to-earnings ratio of Medartis Holding has increased by 5,886.49% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Medartis Holding high compared to other companies?

Yes, the price-to-earnings ratio of Medartis Holding is high compared to other companies.

How does an increase in the price-earnings ratio of Medartis Holding affect the company?

An increase in the price-earnings ratio of Medartis Holding would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Medartis Holding affect the company?

A decrease in the price-earnings ratio of Medartis Holding would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Medartis Holding?

Some factors that influence the price-earnings ratio of Medartis Holding are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Medartis Holding pay?

Over the past 12 months, Medartis Holding paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medartis Holding is expected to pay a dividend of 0 CHF.

What is the dividend yield of Medartis Holding?

The current dividend yield of Medartis Holding is .

When does Medartis Holding pay dividends?

Medartis Holding pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medartis Holding?

Medartis Holding paid dividends every year for the past 0 years.

What is the dividend of Medartis Holding?

For the upcoming 12 months, dividends amounting to 0 CHF are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medartis Holding located?

Medartis Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medartis Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medartis Holding from 6/9/2024 amounting to 0 CHF, you needed to have the stock in your portfolio before the ex-date on 6/9/2024.

When did Medartis Holding pay the last dividend?

The last dividend was paid out on 6/9/2024.

What was the dividend of Medartis Holding in the year 2023?

In the year 2023, Medartis Holding distributed 0 CHF as dividends.

In which currency does Medartis Holding pay out the dividend?

The dividends of Medartis Holding are distributed in CHF.